Yves Panis

Yves Panis

Auto-generated profile, based on publicly available information

Yves Panis

Department of Colorectal Surgery, Groupe Hospitalier Privé Ambroise-Paré Hartmann, Neuilly, France

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2021 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
PDF file
TRTim Raine
Tim Raine
Stefanos BonovasStefanos Bonovas
Stefanos Bonovas
JBJohan Burisch
Johan Burisch
TKTorsten Kucharzik
Torsten Kucharzik
MAMichel Adamina
Michel Adamina
GDGlen Doherty
Glen Doherty
Ulcerative colitis [UC] is a chronic inflammatory bowel disease [IBD] characterised by colonic inflammation extending to a variable extent from the rectum. Care of the patient with UC requires appropriate input from across the multiprofessional team. These guidelines summarise the recommended medical treatment for adults with UC. Other ECCO guidelines consider the approach to UC diagnosis and monitoring,1–3 nursing care,4 management of disease complications,5–7 risk of infection,8 and technical aspects of surgery.9 This document was prepared as part of a process that also led to the publication of a related guideline with recommendations on the surgical care of the patients with UC and on the medical aspects of the management of the patient hospitalised with severe UC. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.

17 October 2021 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
PDF file
ASAntonino Spinelli
Antonino Spinelli
Stefanos BonovasStefanos Bonovas
Stefanos Bonovas
JBJohan Burisch
Johan Burisch
TKTorsten Kucharzik
Torsten Kucharzik
MAMichel Adamina
Michel Adamina
YPYves Panis
Yves Panis
This is the second of a series of two articles reporting the European Crohn’s and Colitis Organisation [ECCO] evidence-based consensus on the management of adult patients with ulcerative colitis [UC]. The first article is focused on medical management, and the present article addresses medical treatment of acute severe ulcerative colitis [ASUC] and surgical management of medically refractory UC patients, including preoperative optimisation, surgical strategies, and technical issues. The article provides advice for a variety of common clinical and surgical conditions. Together, the articles represent an update of the evidence-based recommendations of the ECCO for UC.

1 November 2011 in Annals of Surgery
Verified
Journal Article
Closed access
YPYves Panis
Yves Panis
LMLéon Maggiori
Léon Maggiori
GCGilbert Caranhac
Gilbert Caranhac
FBFrederic Bretagnol
Frederic Bretagnol
EVEric Vicaut
Eric Vicaut
Objectives: This study aimed to identify risk factors of postoperative 30-day mortality (POM) after colorectal cancer resection. Summary: Meta-analyses have failed to demonstrate any significant benefit of laparoscopy in terms of postoperative mortality. This could be explained by the lack of a large sample size. Methods: All patients who underwent colorectal resection for cancer between 2006 and 2008 in France were included. Data were extracted from the French National Health Service Database. A multivariate analysis evaluating risk factors for POM was performed including the following factors: age, gender, tumor location, associated comorbidities, emergency surgery, synchronous liver metastasis, malnutrition, and surgical approach. Results: During the 3-year period, a total of 84,524 colorectal resections for colorectal cancer were performed: 22,359 through laparoscopy (26%) and 62,165 through laparotomy (74%). From 2006 to 2008, laparoscopic approach rate increased from 23% to 29% (P < 0.001). POM was 5.0%: 2% after laparoscopy and 6% after laparotomy (P < 0.001). In multivariate analysis, 7 independent factors were significantly associated with a higher POM: age 70 years or more [P < 0.001, odds ratio (OR): 3.28; (3.00–3.59)], respiratory comorbidity [P < 0.001, OR: 3.16; (2.91–3.37)], vascular comorbidity [P < 0.001, OR: 2.66; (2.48–2.85)], neurologic comorbidity [P < 0.001, OR: 1.78; (1.51–2.09)], emergency surgery [P < 0.001, OR: 2.68; (2.48–2.90)], synchronous liver metastasis [P < 0.001, OR: 2.63; (2.41–2.86)], and preoperative malnutrition [OR: 1.33; (1.19–1.50)]. Laparoscopic surgery [P < 0.001, OR: 0.59; (0.54–0.65)] was independently associated with a significant decreased POM. Conclusions: This all-inclusive national study showed that POM after colorectal cancer surgery is significantly reduced in case of age less than 70 years, elective surgery, and absence of synchronous liver metastasis, malnutrition, respiratory, neurologic, or vascular comorbidity. Furthermore, it is suggested that a laparoscopic surgery is independently associated with a decreased POM. This result, observed at a national level, must be considered when choosing the best surgical approach for colorectal cancer treatment.

1 June 2001 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
JRJ. M. Regimbeau
J. M. Regimbeau
YPY. Panis
Y. Panis
Marc PocardMarc Pocard
Marc Pocard
YBY. Bouhnik
Y. Bouhnik
ALA. Lavergne-Slove
A. Lavergne-Slove
PVP. Valleur
P. Valleur
The aim of this study is to report ten-year results of ileal pouch-anal anastomosis in selected patients with colorectal Crohn's disease for whom coloproctectomy and definitive end ileostomy was the only alternative. 41 patients (22 females/19 males) with a mean age of 36 +/- 13 (range, 16-72) years underwent ileal pouch-anal anastomosis for colorectal Crohn's disease between 1985 to 1998. None had past or present history of anal manifestations or evidence of small-bowel involvement. Diagnosis of Crohn's disease was established preoperatively in 26 patients, on the resected specimen after ileal pouch-anal anastomosis, or after occurrence of Crohn's disease-related complication in 15 patients. Follow-up was 113 +/- 37 months, (18-174) 20 patients having been followed for more than 10 years. There was no postoperative death. Eleven (27 percent) patients experienced Crohn's disease-related complications, 47 +/- 34 months (8-101) after ileal pouch-anal anastomosis: 2 had persistent anal ulcerations with pouchitis and granulomas on pouch biopsy and were treated medically; 2 experienced extrasphincteric abscesses and 7 presented pouch-perineal fistulas which were treated surgically. Among them, 3 patients with persistent perineal fistula despite surgery required definitive end-ileostomy. Of the 20 patients followed for more than 10 years, 7 (35 percent) experienced Crohn's disease-related complications which required pouch excision in 2 (10 percent). Ten years after ileal pouch-anal anastomosis for colorectal Crohn's disease, rates of Crohn's disease-related complications and pouch excision were 35 and 10 percent, respectively. These good long-term results justify for us to propose ileal pouch-anal anastomosis in selected patients with colorectal Crohn's disease (i.e., no past or present history of anal manifestations and no evidence of small-bowel involvement) for whom the only alternative is definitive end ileostomy.

29 April 2008 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
AAA Alves
A Alves
YPY Panis
Y Panis
BLB Lelong
B Lelong
BDB Dousset
B Dousset
SBS Benoist
S Benoist
EVE Vicaut
E Vicaut
Temporary faecal diversion is recommended with a low colorectal, coloanal or ileoanal anastomosis (LA). This randomized study evaluated early (EC; 8 days) versus late (LC; 2 months) closure of the temporary stoma. Patients undergoing rectal resection with LA were eligible to participate. If there was no radiological sign of anastomotic leakage after 7 days, patients were randomized to EC or LC. The primary endpoints were postoperative morbidity and mortality 90 days after the initial resection. Some 186 patients were analysed. There were no deaths within 90 days and overall morbidity rates were similar in the EC and LC groups (31 versus 38 per cent respectively; P = 0·254). Overall surgical complication (both 15 per cent; P = 1·000) and reoperation (both 8 per cent; P = 1·000) rates were similar, but wound complications were more frequent after EC (19 versus 5 per cent; P = 0·007). Small bowel obstruction (3 versus 16 per cent; P = 0·002) and medical complications (5 versus 15 per cent; P = 0·021) were more common with LC. Median (range) hospital stay was reduced by EC (16 (6–59) versus 18 (9–262) days; P = 0·013). Early stoma closure is feasible in selected patients, with reduced hospital stay, bowel obstruction and medical complications, but a higher wound complication rate. Registration number: NCT00428636 (http://www.clinicaltrials.gov).

7 February 2020 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
GFGionata Fiorino
Gionata Fiorino
TLTheodore Lytras
Theodore Lytras
LYLisa Younge
Lisa Younge
CFCatarina Fidalgo
Catarina Fidalgo
SCSofie Coenen
Sofie Coenen
JGJavier P Gisbert
Javier P Gisbert
The management of inflammatory bowel disease [IBD] is complex, and requires tight control of disease activity, close monitoring to avoid treatment side effects, health care professionals with expertise in IBD, and an interdisciplinary, holistic approach. Despite various efforts to standardise structures, processes, and outcomes,1–8 and due to the high variability at the local, national, and international levels, there are still no clear definitions or outcome measures available to establish quality of care standards for IBD patients which are applicable in all contexts and all countries. For this reason, the European Crohn’s and Colitis Organisation [ECCO] supported the construction of a list of criteria summarising current standards of care in IBD. The list comprises 111 quality standard points grouped into three main domains [structure n = 31, process n = 42, outcomes n = 38] and is based on scientific evidence, interdisciplinary expert consensus, and patient-oriented perspectives. The list of proposed criteria is intended to represent the position of ECCO regarding the optimum quality of care that should be available to patients. Since health care systems and regulations vary considerably between countries, this list may require adaptation at local and national levels. It is recognised that not all these criteria that have been identified as optimal will be available in every unit. However, ECCO will continue its efforts to develop and coordinate projects and initiatives that will help to guarantee optimal quality of care for all IBD patients.